MktsMarkets

PMV Pharmaceuticals, Inc.
NASDAQ: PMVPKey statistics
PMVP News
Stories mentioning PMVP from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 15,330 | 15,826 | 18,210 | 18,400 | 17,441 | 13,766 | 16,947 | 14,628 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 19,019 | 19,241 | 22,522 | 22,879 | 21,564 | 25,169 | 21,888 | 20,170 |
| Operating Income (Loss) | (19,019) | (19,241) | (22,522) | (22,879) | (21,564) | (25,169) | (21,888) | (20,170) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 981.00 | 1,230 | 1,457 | 1,674 | 1,931 | 2,168 | 2,736 | 2,784 |
| Pretax Income | (18,038) | (18,011) | (21,065) | (21,205) | (19,633) | (23,001) | (19,152) | (17,386) |
| Tax Provision | 26.00 | (6.00) | 5.00 | (2,197) | 74.00 | (16,173) | ||
| Net Income (Loss) | (18,038) | (18,037) | (21,059) | (21,210) | (17,436) | (23,000) | (19,226) | (1,213) |
| Earnings Per Share (Basic) | (0.34) | (0.34) | (0.40) | (0.41) | (0.34) | (0.45) | (0.37) | (0.02) |
| Earnings Per Share (Diluted) | (0.34) | (0.34) | (0.40) | (0.41) | (0.34) | (0.45) | (0.37) | (0.02) |
| Weighted Average Shares Outstanding (Basic) | 53,332 | 52,542 | 52,993 | 52,011 | 51,952 | 51,579 | 51,574 | 51,479 |
| Weighted Average Shares Outstanding (Diluted) | 53,332 | 52,542 | 52,993 | 52,011 | 51,952 | 51,579 | 51,574 | 51,479 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PMVP
PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) is a stock listed on the Nasdaq Stock Market under the ticker symbol PMVP. It last traded at $1.27 (Oct 23, 2026, 4:00 PM ET), down 2.7% on the day. That gives PMV Pharmaceuticals a market capitalisation of $95.9M.
Over the past 52 weeks PMVP has traded between $1.02 and $1.91.
For the quarter ended Mar 31, 2026 it reported a net loss of $18.0M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$18.0M |
| Dec 31, 2025 | — | -$18.0M |
| Sep 30, 2025 | — | -$21.1M |
| Jun 30, 2025 | — | -$21.2M |
From PMV Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…